Promises and challenges of personalized medicine to guide ARDS therapy. (2021)
Attributed to:
Hydroxymethylglutaryl-CoA reductase inhibition with simvastatin in Acute lung injury to Reduce Pulmonary dysfunctio
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/s13054-021-03822-z
PubMed Identifier: 34814925
Publication URI: http://europepmc.org/abstract/MED/34814925
Type: Journal Article/Review
Volume: 25
Parent Publication: Critical care (London, England)
Issue: 1
ISSN: 1364-8535